CAUTION: Investigational device. Limited by United States law to investigational use. FIRST U.S. PATIENT ENROLLED IN GORE® VIAFORT Vascular Stent ILIOFEMORAL pivotal study FLAGSTAFF, Ariz., June 6, 2023 /PRNewswire/ — W. L. Gore & Associates (Gore) has announced that the first U.S. patient has been enrolled […]
Tag: Gore
GORE ANNOUNCES FIRST U.S. ENROLLMENT FOR THE GORE® VIAFORT VASCULAR STENT IVC STUDY
CAUTION: Investigational device. Limited by United States law to investigational use. FIRST U.S. PATIENT ENROLLED IN GORE® VIAFORT Vascular Stent pivotal study FLAGSTAFF, Ariz., March 28, 2023 /PRNewswire/ — W. L. Gore & Associates (Gore) has announced that the first U.S. patient has been […]
GORE COMPLETES FIRST IN-HUMAN IMPLANTS OF THE GORE® VIAFORT VASCULAR STENT
CAUTION: Investigational device. Limited by United States law to investigational use. W. L. Gore & Associates initiates its GORE® VIAFORT Device Pivotal Clinical Study for the treatment of inferior vena cava occlusive disease. FLAGSTAFF, Ariz., Oct. 28, 2022 /PRNewswire/ — W. L. Gore & Associates (Gore) […]
GORE COMPLETES ENROLLMENT IN THE GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS EXPAND REGISTRY
This registry will confirm safety and performance of the VBX Stent Graft in peripheral vessels in patients who require interventional treatment in a variety of applications and diseases. PUTZBRUNN, Germany, Oct. 27, 2022 /PRNewswire/ — W. L. Gore & Associates, Inc. (Gore) announced […]
Five-year Results Of The GORE® EXCLUDER® Iliac Branch Endoprosthesis Pivotal U.S. Multicenter Study Confirm Safety, Efficacy and Durability
FLAGSTAFF, Ariz., Aug. 19, 2021 /PRNewswire/ — W. L. Gore & Associates (Gore), today announced that five-year results of the U.S. prospective, multicenter study (N = 63) of endovascular repair of iliac aneurysms using the GORE® EXCLUDER® Iliac Branch Endoprosthesis (IBE) were presented at the […]
Gore REDUCE Clinical Study Five-Year Results Demonstrate That PFO Closure With The GORE® CARDIOFORM Septal Occluder Provides Safe Long-Term Reduction Of Recurrent Stroke
– Published in the New England Journal of Medicine (NEJM), the REDUCE Study continues to show the largest reduction in recurrent ischemic stroke in all PFO shunt sizes over medical therapy alone.*,¹ – Long-term results highlight GORE® CARDIOFORM Septal Occluder can be […]
W. L. Gore & Associates Announces Encouraging Six-Month Results With Its Novel Biosynthetic Tissue Valve
FLAGSTAFF, Ariz., Nov. 30, 2020 /PRNewswire/ — W. L. Gore & Associates, Inc. (Gore), a global leader in providing solutions for cardiovascular disease, today announced encouraging clinical results from its early feasibility study evaluating the safety and performance of its pulmonary valved […]
Gore Innovation Center Announces Collaboration With Robotics Startup Moray Medical
Startups join Gore Innovation Center to bring new technologies to market. SANTA CLARA, Calif., Feb. 26, 2020 /PRNewswire/ — The Gore Innovation Center today announced a collaboration with Moray Medical, a 2-year-old startup developing precision automated delivery systems for endovascular procedures. The Gore Innovation Center […]
Gore Named a Fortune 100 Best Company to Work For®
NEWARK, Del., Feb. 18, 2020 /PRNewswire/ — W. L. Gore & Associates — a materials science company known for its innovative products and work environment — earned a spot on the 2020 Fortune 100 Best Companies to Work For® list, announced today. This […]
First U.S. Patient Receives GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL
FLAGSTAFF, Ariz.–(BUSINESS WIRE)–W. L. Gore & Associates, Inc. (Gore) announces the first U.S. implant of the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System. The successful procedure was performed by William Jordan, M.D., chief of the Division of Vascular […]